GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xiamen Kingdomway Group 002626.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

17.42

-0.17%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.37bn

FY2016FY2025

Net income

CN¥339.9m

FY2016FY2025

Free cash flow

CN¥326.5m

FY2016FY2025

Shareholders' equity

CN¥4.46bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥3.37bnCN¥3.24bnCN¥3.10bnCN¥3.01bnCN¥3.62bnCN¥3.50bnCN¥3.19bnCN¥2.87bnCN¥2.08bnCN¥1.66bn
Gross profitCN¥1.32bnCN¥1.24bnCN¥1.14bnCN¥1.14bnCN¥1.71bnCN¥1.82bnCN¥1.51bnCN¥1.49bnCN¥991.0mCN¥683.6m
Research and developmentCN¥75.6mCN¥69.4mCN¥58.2mCN¥71.9mCN¥82.9mCN¥73.7mCN¥65.8mCN¥69.1mCN¥46.9mCN¥44.4m
Operating incomeCN¥532.6mCN¥482.3mCN¥356.0mCN¥312.4mCN¥937.3mCN¥1.15bnCN¥681.4mCN¥873.0mCN¥569.9mCN¥365.4m
Net incomeCN¥339.9mCN¥342.0mCN¥276.7mCN¥257.4mCN¥788.9mCN¥959.2mCN¥450.7mCN¥687.3mCN¥474.1mCN¥299.8m
Diluted earnings per share0.540.570.440.421.281.570.721.100.770.48

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥7.71bnCN¥6.39bnCN¥5.35bnCN¥5.36bnCN¥5.85bnCN¥5.15bnCN¥4.70bnCN¥4.59bnCN¥3.32bnCN¥3.10bn
Cash and short-term investments—CN¥1.34bnCN¥910.6mCN¥787.4mCN¥769.6mCN¥855.7mCN¥718.1mCN¥488.0mCN¥437.3mCN¥840.6m
Total liabilitiesCN¥3.22bnCN¥2.07bnCN¥1.42bnCN¥1.70bnCN¥1.82bnCN¥1.66bnCN¥1.74bnCN¥1.57bnCN¥833.6mCN¥920.9m
DebtCN¥1.51bnCN¥1.08bnCN¥711.1mCN¥1.08bnCN¥1.12bnCN¥974.4mCN¥1.23bnCN¥1.15bnCN¥472.4mCN¥684.7m
Shareholders' equityCN¥4.46bnCN¥4.28bnCN¥3.93bnCN¥3.65bnCN¥3.97bnCN¥3.43bnCN¥2.91bnCN¥3.02bnCN¥2.48bnCN¥2.16bn
Shares outstanding628m603m633m616m615m611m628m624m614m626m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥556.0mCN¥521.1mCN¥664.5mCN¥695.1mCN¥847.3mCN¥967.8mCN¥918.4mCN¥886.9mCN¥487.2mCN¥374.1m
Capital spending−CN¥229.6m−CN¥364.6m−CN¥251.8m−CN¥161.7m−CN¥344.6m−CN¥249.7m−CN¥175.7m−CN¥79.1m−CN¥90.0m−CN¥20.6m
Free cash flowCN¥326.5mCN¥156.5mCN¥412.7mCN¥533.4mCN¥502.8mCN¥718.1mCN¥742.6mCN¥807.8mCN¥397.2mCN¥353.4m
Dividends paid−CN¥274.6m−CN¥145.7m−CN¥159.2m−CN¥366.0m−CN¥366.0m−CN¥366.0m−CN¥491.7m−CN¥273.7m−CN¥140.3m−CN¥48.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥959.7mCN¥813.4mCN¥761.1mCN¥875.8mCN¥901.2mCN¥827.2mCN¥897.3mCN¥819.3m
Gross profitCN¥396.5mCN¥308.9mCN¥276.8mCN¥375.2mCN¥327.0mCN¥345.3mCN¥346.7mCN¥328.7m
Operating incomeCN¥176.9mCN¥112.1mCN¥76.5mCN¥149.1mCN¥138.4mCN¥153.0mCN¥180.2mCN¥124.7m
Net incomeCN¥104.5mCN¥65.6m−CN¥20.9mCN¥113.5mCN¥125.6mCN¥121.7mCN¥121.2mCN¥90.7m
Diluted earnings per share0.170.10-0.030.180.200.190.200.15
Cash from operations———CN¥185.0mCN¥218.0mCN¥109.0mCN¥244.0mCN¥142.0m
Capital spending−CN¥234.0m−CN¥219.0m−CN¥74.0m−CN¥43.0m−CN¥46.0m−CN¥64.0m−CN¥141.0m−CN¥102.0m
Free cash flow———CN¥142.0mCN¥172.0mCN¥45.0mCN¥103.0mCN¥40.0m
Total assetsCN¥7.16bnCN¥7.65bnCN¥7.71bnCN¥8.38bnCN¥6.88bnCN¥6.74bnCN¥6.39bnCN¥5.87bn
Cash and short-term investments———CN¥3.14bnCN¥1.72bnCN¥1.63bnCN¥1.34bnCN¥1.09bn
DebtCN¥1.36bnCN¥1.31bnCN¥1.51bnCN¥1.18bnCN¥1.29bnCN¥1.49bnCN¥903.8mCN¥747.4m
Shareholders' equityCN¥4.20bnCN¥4.48bnCN¥4.46bnCN¥4.54bnCN¥4.33bnCN¥4.39bnCN¥4.28bnCN¥4.03bn

Financial ratios

Data as of 4 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin39.4%38.2%36.6%38.0%47.3%51.8%
Operating margin15.8%14.9%11.5%10.4%25.9%32.9%
Net margin10.1%10.6%8.9%8.6%21.8%27.4%
Return on equity7.6%8.0%7.0%7.1%19.9%28.0%
Return on assets4.4%5.4%5.2%4.8%13.5%18.6%
Free cash flow yield7.8%9.1%9.0%8.6%12.0%12.4%
Revenue growth3.9%4.4%3.1%-16.8%3.2%9.8%
Earnings growth-0.6%23.6%7.5%-67.4%-17.8%112.8%
Current ratio3.10x2.18x3.08x2.07x3.25x1.94x
Debt to equity0.34x0.21x0.13x0.10x0.20x0.19x
Equity ratio57.8%67.0%73.3%68.1%67.9%66.5%
Interest coverage8.87x15.32x8.84x7.82x25.12x30.70x
R&D as a share of sales2.2%2.1%1.9%2.4%2.3%2.1%
Buybacks as a share of market value-4.2%4.8%-2.8%-0.2%-0.7%2.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.8%-0.8%10.8%
Operating income19.5%-14.3%15.6%
Net income9.7%-18.7%11.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin38.8%38.1%42.2%43.7%
Operating margin15.4%13.2%19.0%20.7%
Net margin10.3%9.6%14.9%16.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings36.426.637.449.624.422.127.110.924.329.0
Price to sales3.72.83.34.25.36.03.82.65.55.2

Dividends and splits

Per share, in the currency the company pays

Paid for 14 years. Last went ex-dividend on 10 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.400.400.200.200.600.600.600.80
  • 2-for-1 split · 9 Jun 2015
  • 8-for-5 split · 6 Jun 2014
  • 2-for-1 split · 28 May 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.